China Pharma Holdings Net Worth 2010-2023 | CPHI

Interactive chart of historical net worth (market cap) for China Pharma Holdings (CPHI) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. China Pharma Holdings net worth as of May 02, 2024 is $0B.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.004B $0.007B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.673B 5.66
Dr Reddy's Laboratories (RDY) India $12.346B 19.52
Aspen Pharmacare (APNHY) South Africa $5.328B 0.00
BridgeBio Pharma (BBIO) United States $5.058B 0.00
Bausch Health Cos (BHC) Canada $3.197B 2.49
Amphastar Pharmaceuticals (AMPH) United States $2.056B 14.07
Supernus Pharmaceuticals (SUPN) United States $1.654B 0.00
Taysha Gene Therapies (TSHA) United States $0.453B 0.00
Generation Bio (GBIO) United States $0.193B 0.00
Personalis (PSNL) United States $0.078B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.022B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00